Metastasis is the final common lethal pathway for most cancer patient's demise and once cancer has metastasized, it was generally considered incurable.
Radiation oncology is playing an increasingly important role in theranostics—but building a successful program requires more than clinical interest alone.
The use of radiotherapy (RT) in the management of leukemia has evolved. Historically, RT was critical for disease control in sanctuary sites, such as the central nervous system (CNS) and testes.
Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.
Glioblastoma (GBM) patients with leptomeningeal disease (LMD) are a subgroup of GBM patients with distinctly poor prognosis. That being said, treatment options should be considered based on different clinical factors.
For the practical radiation oncology program, this activity includes three speakers for education on the following complex presentations for managing advanced stage gynecologic cancer patients.
This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer.
Immunotherapy has transformed the care of patients with recurrent/metastatic head and neck cancer but integration into definitive management has been more challenging.
Facebook
X
LinkedIn
Forward
